Concepedia

Publication | Open Access

Phase Ia study of the indoleamine 2,3-dioxygenase 1 (IDO1) inhibitor navoximod (GDC-0919) in patients with recurrent advanced solid tumors

DOIFull Paper Access

150

Citations

35

References

2018

Year

Asha Nayak-Kapoor, Zhonglin Hao, Ramses Sadek, Robin Dobbins, Lisa Marshall, Nicholas N. Vahanian, W. Jay Ramsey, Eugene P. Kennedy, Mario R. Mautino, Charles J. Link,
Journal for ImmunoTherapy of Cancer

Abstract

ClinicalTrials.gov identifier: NCT02048709 .

References

YearCitations

Page 1